Axiom Investors LLC Bio N Tech Se Transaction History

Axiom Investors LLC

  • $11.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$216.64 - $362.52 $47.4 Million - $79.3 Million
-218,678 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$205.93 - $447.23 $15.7 Million - $34 Million
76,066 Added 53.34%
218,678 $59.7 Million
Q2 2021

Aug 13, 2021
BUY
$113.32 - $241.49 $16.2 Million - $34.4 Million
142,612 New
142,612 $31.9 Million

Others Institutions Holding BNTX

# of Institutions
328
Shares Held
40.6M
Call Options Held
845K
Put Options Held
1.23M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Axiom Investors LLC Portfolio

Follow Axiom Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email